BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3003955)

  • 1. Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumor.
    Ts'ao C; Galluzzo TS; Hart SJ; Ng AS; Sorenson PG; Subbarao V
    Thromb Haemost; 1985 Dec; 54(4):768-72. PubMed ID: 3003955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant properties of extracellular slime substance produced by Staphylococcus epidermidis.
    Bykowska K; Ludwicka A; Wegrzynowicz Z; Lopaciuk S; Kopeć M
    Thromb Haemost; 1985 Dec; 54(4):853-6. PubMed ID: 4089818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet interaction with a pancreatic ascites tumor.
    Hamilton J; Subbarao V; Granack K; Ts'ao C
    Am J Pathol; 1986 Jan; 122(1):160-8. PubMed ID: 3510553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunoglobulin with antibody activity against blood coagulation factors.
    Antonucci M; Berard M; Beaumont JL
    J Med; 1986; 17(3-4):149-65. PubMed ID: 3473163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant activity of captopril.
    Brecher AS; Murrey SJ; Gray KD; Poulimenos JN
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):99-105. PubMed ID: 18209575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotting alterations in primary systemic amyloidosis.
    Gamba G; Montani N; Anesi E; Palladini G; Capezzera M; Soldavini E; Merlini G
    Haematologica; 2000 Mar; 85(3):289-92. PubMed ID: 10702818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated sericin is a novel anticoagulant influencing the blood coagulation cascade.
    Sano M; Tamada Y; Niwa K; Morita T; Yoshino G
    J Biomater Sci Polym Ed; 2009; 20(5-6):773-83. PubMed ID: 19323889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity in cell homogenate of adult T cell leukemia.
    Wada H; Tomeoku M; Deguchi A; Suzuki H; Mori Y; Ito M; Deguchi K; Shirakawa S
    Thromb Haemost; 1988 Apr; 59(2):197-201. PubMed ID: 2898816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.